1. Home
  2. CSBR vs IROQ Comparison

CSBR vs IROQ Comparison

Compare CSBR & IROQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CSBR
  • IROQ
  • Stock Information
  • Founded
  • CSBR 1985
  • IROQ 1883
  • Country
  • CSBR United States
  • IROQ United States
  • Employees
  • CSBR N/A
  • IROQ N/A
  • Industry
  • CSBR Biotechnology: Biological Products (No Diagnostic Substances)
  • IROQ Savings Institutions
  • Sector
  • CSBR Health Care
  • IROQ Finance
  • Exchange
  • CSBR Nasdaq
  • IROQ Nasdaq
  • Market Cap
  • CSBR 90.0M
  • IROQ 84.4M
  • IPO Year
  • CSBR 1986
  • IROQ 2011
  • Fundamental
  • Price
  • CSBR $6.53
  • IROQ $26.05
  • Analyst Decision
  • CSBR Strong Buy
  • IROQ
  • Analyst Count
  • CSBR 1
  • IROQ 0
  • Target Price
  • CSBR $12.00
  • IROQ N/A
  • AVG Volume (30 Days)
  • CSBR 10.6K
  • IROQ 11.4K
  • Earning Date
  • CSBR 12-12-2025
  • IROQ 10-31-2025
  • Dividend Yield
  • CSBR N/A
  • IROQ 1.54%
  • EPS Growth
  • CSBR N/A
  • IROQ 157.16
  • EPS
  • CSBR 0.21
  • IROQ 1.60
  • Revenue
  • CSBR $56,878,000.00
  • IROQ $27,979,000.00
  • Revenue This Year
  • CSBR $7.31
  • IROQ N/A
  • Revenue Next Year
  • CSBR $12.01
  • IROQ N/A
  • P/E Ratio
  • CSBR $30.46
  • IROQ $16.24
  • Revenue Growth
  • CSBR 10.11
  • IROQ 24.68
  • 52 Week Low
  • CSBR $4.07
  • IROQ $21.44
  • 52 Week High
  • CSBR $11.99
  • IROQ $26.50
  • Technical
  • Relative Strength Index (RSI)
  • CSBR 39.54
  • IROQ 56.27
  • Support Level
  • CSBR $6.67
  • IROQ $25.96
  • Resistance Level
  • CSBR $6.85
  • IROQ $26.14
  • Average True Range (ATR)
  • CSBR 0.17
  • IROQ 0.08
  • MACD
  • CSBR -0.05
  • IROQ 0.02
  • Stochastic Oscillator
  • CSBR 1.79
  • IROQ 63.64

About CSBR Champions Oncology Inc.

Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.

About IROQ IF Bancorp Inc.

IF Bancorp Inc is a holding company mainly engaged in the business of directing, planning, and coordinating the business activities of Iroquois Federal. The company, in association, takes deposits from the general public and invests those deposits together with funds generated from operations and borrowings in various loans such as multi-family residential and mortgage loans, commercial real estate loans, home equity lines of credit, consumer loans, etc., and offers a variety of deposit accounts and alternative delivery channels. In addition to the traditional banking products and services, the group also offers a full line of property and casualty insurance products, annuities, mutual funds, individual securities, managed accounts, and other financial services.

Share on Social Networks: